Robert A. Beardsley

CIK: 0001310845

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (33.3%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ABUS

Arbutus Biopharma Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

ABUS
Arbutus Biopharma Corp
Oct 1, 2026
Disposition(D)
Direct
17.9K shares at avg. $5.00$90K
ABUS
Arbutus Biopharma Corp
Sep 18, 2026
Exercise(M)
Direct
52.5K shares at avg. $3.20$168K
ABUS
Arbutus Biopharma Corp
Sep 18, 2026
Exercise(M)
Direct
78.8K shares at avg. $4.24$334K
ABUS
Arbutus Biopharma Corp
Sep 18, 2026
Tax Payment(F)
Direct
99.1K shares at avg. $5.07$502K
ABUS
Arbutus Biopharma Corp
Jun 8, 2026
Award(A)
Stock Option (Right to Buy)
Direct
78.8K shares-
ABUS
Arbutus Biopharma Corp
Mar 18, 2025
Award(A)
Stock Option (Right to Buy)
Direct
157.6K shares-

		Type	Shares	Price		Ownership
Oct 1, 2026	ABUS Arbutus Biopharma Corp	Disposition(D)	17,948	$5.00	$89,740	Direct
Sep 18, 2026	ABUS Arbutus Biopharma Corp	Exercise(M)	52,533	$3.20	$168,106	Direct
Sep 18, 2026	ABUS Arbutus Biopharma Corp	Exercise(M)	78,800	$4.24	$334,112	Direct
Sep 18, 2026	ABUS Arbutus Biopharma Corp	Tax Payment(F)	99,057	$5.07	$502,219	Direct
Jun 8, 2026	ABUS Arbutus Biopharma Corp	Award(A) Stock Option (Right to Buy)	78,800	-	-	Direct
Mar 18, 2025	ABUS Arbutus Biopharma Corp	Award(A) Stock Option (Right to Buy)	157,600	-	-	Direct

1-6 of 6 transactions

About Beardsley Robert A

Beardsley Robert A (SEC CIK 0001310845) files insider reports with the SEC as Director of Arbutus Biopharma Corp (ABUS).

Signal8 holds 5 ownership filings by Beardsley Robert A (1 Form 3, 4 Form 4), filed between Mar 6, 2025 and Oct 7, 2026. Those filings report 6 transactions, from Mar 18, 2025 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Beardsley Robert A's filings is in WARMINSTER, PA.

Recent filings by Beardsley Robert A

Oct 1, 2026: Disposition to issuer transaction of ABUS shares (Form 4, code D).
Sep 18, 2026: Option exercises of ABUS shares (2 lines, Form 4, code M).
Sep 18, 2026: Tax withholding of ABUS shares (Form 4, code F).
Jun 8, 2026: Grant or award of ABUS derivative securities (Form 4, code A).
Mar 18, 2025: Grant or award of ABUS derivative securities (Form 4, code A).

Other insiders filing for Arbutus Biopharma Corp (ABUS)

Nguyen Tuan, Chief Financial Officer
Sawhney Roger, Director
Androski Lindsay, President and CEO
Hasija Anuj, Director
Bishop Joseph E, Director
Gline Matthew, Director

How to read Form 4 transaction codes